Factors influencing global antiretroviral procurement prices
Open Access
- 18 November 2009
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 9 (1) , S6
- https://doi.org/10.1186/1471-2458-9-s1-s6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databasesBulletin of the World Health Organization, 2009
- Essential medicines pricing—reform neededThe Lancet, 2009
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysisPublished by Elsevier ,2008
- HIV/AIDS Drugs for Sub-Saharan Africa: How Do Brand and Generic Supply Compare?PLOS ONE, 2007
- What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?Current HIV Research, 2007
- Negotiating antiretroviral drug prices: the experience of the Andean countriesHealth Policy and Planning, 2007
- Examining the production costs of antiretroviral drugsAIDS, 2006
- The pricing and procurement of antiretroviral drugs: an observational study of data from the Global FundPublished by WHO Press ,2006
- Price Differentiation and Transparency in the Global Pharmaceutical MarketplacePharmacoEconomics, 2005
- Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and PatentsInternational Journal of Health Economics and Management, 2003